Form 4 Precigen Inc For: 13 March
#Precigen Inc #Form 4 #SEC filing #insider trading #March 13
📌 Key Takeaways
- Form 4 filing submitted for Precigen Inc on March 13
- Form 4 relates to insider trading disclosures
- Indicates changes in holdings by company insiders
- Standard regulatory filing for publicly traded companies
🏷️ Themes
Regulatory Compliance, Corporate Governance
📚 Related People & Topics
SEC filing
Type of financial statements in the United States
# SEC Filing An **SEC filing** is a formal financial statement or regulatory document submitted to the **U.S. Securities and Exchange Commission (SEC)**. These filings are mandatory requirements designed to ensure transparency, providing a standardized method for disclosing material information to ...
Entity Intersection Graph
Connections for SEC filing:
Mentioned Entities
Deep Analysis
Why It Matters
This Form 4 filing matters because it provides transparency into insider trading activity at Precigen Inc, a biotechnology company focused on gene and cell therapies. Investors closely monitor these filings to gauge executive confidence in the company's future prospects, as insider buying can signal optimism while selling may indicate concerns. The timing and volume of transactions can influence stock price movements and investor sentiment toward the company's pipeline developments.
Context & Background
- Form 4 filings are required by the SEC whenever corporate insiders (officers, directors, or beneficial owners) buy or sell company stock
- Precigen Inc (NASDAQ: PGEN) is a biotech company specializing in gene and cell therapies with a focus on immuno-oncology and autoimmune diseases
- Insider trading filings must be submitted within two business days of the transaction under SEC regulations
- The company was formerly known as Intrexon Corporation before rebranding to Precigen in 2020
What Happens Next
Investors will analyze the specific details of the Form 4 filing once available, including the insider's identity, transaction type (buy/sell), number of shares, and price per share. Market reaction may follow as traders interpret the insider's move in context of recent company developments. Additional Form 4 filings from other insiders may occur in coming days if there's coordinated trading activity.
Frequently Asked Questions
A Form 4 is a mandatory SEC filing that reports changes in ownership of company securities by corporate insiders. It must be filed within two business days of any transaction involving company stock by officers, directors, or beneficial owners.
Investors monitor Form 4 filings to track insider trading activity, which can indicate executive confidence in the company. Significant insider buying often signals optimism about future prospects, while large selling may raise concerns about valuation or challenges ahead.
Form 4 filings include the insider's name and position, transaction date, type of transaction (purchase, sale, option exercise), number of shares, price per share, and remaining ownership stake. This provides transparency about insider trading activities.
The market impact depends on the transaction details—large insider purchases typically boost investor confidence and may support the stock price, while significant selling could pressure shares. The reaction also depends on the insider's role and the transaction's size relative to their holdings.
Precigen is a biotechnology company developing gene and cell therapies, particularly in immuno-oncology and autoimmune diseases. The company uses proprietary technologies to create precision medicines targeting various medical conditions.